Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF as Neoadjuvant and Adjuvant Therapy for Stage II and III Colon Cancer
NCT00262808Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Mar 2004
- Primary completion
- Sep 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in colon cancer, sponsored by University of Rochester. Started Mar 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00262808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262808.